Additionally, the mitochondrial dysfunction identified in our analysis—marked by reduced ATP levels and increased ROS—reflects miR-210’s targeting of genes such as ISCU1/2 and SDHD, also reported in tumour cells and studied as hypoxia biomarkers [99]. Here, SDHD is linked to neoplasm.